• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.47% Nasdaq Up 0.39%

    Biogen Inc. (BIIB)

    -NasdaqGS
    422.11 Down 0.81(0.19%) 4:00PM EDT
    |After Hours : 425.00 Up 2.89 (0.68%) 5:35PM EDT
    Add to Portfolio
    Prev Close:422.92
    Open:425.19
    Bid:424.00 x 200
    Ask:426.33 x 200
    1y Target Est:480.67
    Beta:0.58
    Next Earnings Date:24-Apr-15BIIB Earnings announcement
    Day's Range:420.17 - 426.17
    52wk Range:275.39 - 480.18
    Volume:1,224,340
    Avg Vol (3m):1,840,160
    Market Cap:99.03B
    P/E (ttm):34.12
    EPS (ttm):12.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BIIB

    Comparison

    Symbol% ChgMkt Cap
    BIIBDown 0.19%99.03B
    PFEDown 0.34%213.84B

    Key Statistics

    Forward P/E (1 yr):21.16
    P/S (ttm):10.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :16.98
    Quarterly EPS Est (Mar-15) :3.91
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback